MoneyWorks4Me

Lupin informs about board meeting

25 Oct 2023 Evaluate

Pursuant to Regulation 29(1)(a) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, Lupin has informed that a meeting of the Board of Directors of the Company will be held on Wednesday, November 8, 2023, to consider and take on record the unaudited financial results of the Company for the quarter and half-year ended September 30, 2023.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1796.05
Dr. Reddys Labs. 1203.20
Cipla 1338.20
Lupin 2017.30
Zydus Lifesciences 1128.20
View more..